Despite advances in stent technology for percutaneous coronary intervention (PCI) in the treatment of coronary disease, these procedures can be complicated by stent failure manifested as intracoronary stent restenosis (ISR). Even with advances in stent technology and medical therapy, this complication is reported to affect around 10% of all percutaneous coronary intervention (PCI) procedures. Depending on stent type (drug-eluting versus bare metal), ISR has subtle differences in mechanism and timing and offers different challenges in diagnosing etiology and subsequent treatment options
Purpose: Given the limited salvage options for in-stent restenosis (ISR) of drug-eluting stents (DES...
<p><strong><em>Background: </em></strong><em>Despite major advances in percutaneous coronary interve...
In patients with in-stent restenosis (ISR) inside bare metal stents, drug-eluting stents reduce the ...
Despite advances in stent technology for percutaneous coronary intervention (PCI) in the treatment o...
The occurrence of in-stent restenosis (ISR) still remains a daunting challenge in the current era, d...
In-stent restenosis concerning the coronary artery refers to the blood clotting-caused re-narrowing ...
The optimal percutaneous treatment of drug-eluting stent (DES) in-stent restenosis (ISR) and the cor...
BACKGROUND: Drug-eluting stents (DES) represent a significant improvement in the treatment of corona...
The introduction of the drug-eluting stent (DES) proved to be an important step forward in reducing ...
Drug-eluting stents (DESs) have minimized the limitations of bare-metal stents (BMSs) after percutan...
In-stent restenosis (ISR) still represents a frequent limitation of percutaneous coronary interventi...
To the Editor, Although the use of new stents has improved the results after coronary angioplasty, t...
Coronary heart disease is a major cause of death and disability in developed countries. Stent implan...
AbstractPurposeGiven the limited salvage options for in-stent restenosis (ISR) of drug-eluting stent...
BACKGROUND: In-stent restenosis remains the major limitation of percutaneous coronary intervention (...
Purpose: Given the limited salvage options for in-stent restenosis (ISR) of drug-eluting stents (DES...
<p><strong><em>Background: </em></strong><em>Despite major advances in percutaneous coronary interve...
In patients with in-stent restenosis (ISR) inside bare metal stents, drug-eluting stents reduce the ...
Despite advances in stent technology for percutaneous coronary intervention (PCI) in the treatment o...
The occurrence of in-stent restenosis (ISR) still remains a daunting challenge in the current era, d...
In-stent restenosis concerning the coronary artery refers to the blood clotting-caused re-narrowing ...
The optimal percutaneous treatment of drug-eluting stent (DES) in-stent restenosis (ISR) and the cor...
BACKGROUND: Drug-eluting stents (DES) represent a significant improvement in the treatment of corona...
The introduction of the drug-eluting stent (DES) proved to be an important step forward in reducing ...
Drug-eluting stents (DESs) have minimized the limitations of bare-metal stents (BMSs) after percutan...
In-stent restenosis (ISR) still represents a frequent limitation of percutaneous coronary interventi...
To the Editor, Although the use of new stents has improved the results after coronary angioplasty, t...
Coronary heart disease is a major cause of death and disability in developed countries. Stent implan...
AbstractPurposeGiven the limited salvage options for in-stent restenosis (ISR) of drug-eluting stent...
BACKGROUND: In-stent restenosis remains the major limitation of percutaneous coronary intervention (...
Purpose: Given the limited salvage options for in-stent restenosis (ISR) of drug-eluting stents (DES...
<p><strong><em>Background: </em></strong><em>Despite major advances in percutaneous coronary interve...
In patients with in-stent restenosis (ISR) inside bare metal stents, drug-eluting stents reduce the ...